New Delhi [India], January 16 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Saturday wished Prime Minister Narendra Modi success in launching the vaccination rollout in the country.
Pune (Maharashtra) [India], January 12 (ANI): The Serum Institute of India (SII) makes 70 to 80 million doses every month and planning is underway for distribution to India and foreign countries, said Adar Poonawalla, CEO and Owner, SII.
Pune (Maharashtra) [India], January 12 (ANI): After the first consignment containing vials of coronavirus vaccine "Covishield" were dispatched from the Pune factory, Adar Poonawalla, CEO, Serum Institute of India on Tuesday termed it a historic moment and said the main challenge is to mak
New Delhi [India], January 3 (ANI): Covishield, India's first COVID-19 vaccine is approved, safe, effective and ready for roll-out in the coming weeks, said Serum Institute of India Chief Executive Officer Adar Poonawalla on Sunday.
Pune (Maharashtra) [India], December 28 (ANI): In what could be termed as New Year gift, Adar Poonawalla, Chief Executive Officer, Serum Institute of India on Monday said 40-50 million doses of COVID-19 vaccine have already been stockpiled, adding that Covishield rollout is expected in Ja
Mumbai (Maharashtra) [India], December 22 (ANI): The screen adaption of Aravind Adiga's Man Booker Prize-winning novel, 'The White Tiger' is set to premiere on January 22, announced Netflix on Monday (local time).
New Delhi [India], December 16 (ANI/SRV Media): 17th Convocation Ceremony of Symbiosis International University will be held online on Thursday, 17th December 2020 at 11 am.
New Delhi [India], December 11 (ANI): Uzbekistan has given his "in principle concurrence" to joining the International North-South Transport Corridor (INSTC), Ministry of External Affairs (MEA) said on Friday.
New Delhi [India], December 7 (ANI): After Serum Institute India (SII) applied for the emergency use authorisation of its coronavirus vaccine "COVISHIELD", its CEO Adar Poonawala expressed gratitude to Prime Minister Narendra Modi and the central government for the support.
New Delhi [India], December 7 (ANI): The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 vaccine "Covishield" in the country.
New Delhi [India], November 29 (ANI): After a Chennai-based man claimed that he suffered neurological and psychological side effects after taking a shot of COVID-19 vaccine candidate Covishield during the human trial, being conducted by Serum Institute of India's (SII), the Pune-based com
Pune (Maharashtra) [India], November 28 (ANI): Hours after Prime Minister Narendra Modi visited Pune-based Serum Institute of India (SII), its Chief Executive Officer Adar Poonawalla said that he was amazed by the Prime Minister's knowledge about vaccines and vaccine production.